Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-count bottles, (NDC: 68788-7781-6), d) 90-count bottles (NDC: 68788-7781-9), e) 120-count bottles (NDC: 68788-7781-8), Rx only, Mfg: Dr. Reddy's Laboratories Limited.

This recall is currently active, issued July 12, 2023. It was issued by Preferred Pharmaceuticals, Inc..

Company

Preferred Pharmaceuticals, Inc.

Recall Initiated

June 26, 2023

Posted

July 12, 2023

Recall Number

D-0894-2023

Voluntary / Mandated

Voluntary: Firm initiated

Quantity

541 Bottles

Firm Location

Anaheim, CA, United States

Official Source

View on FDA website ↗